Evidence map›Paper›PMID 36050381›Full record

ArticleScientific reports2022

Long-term blast control in high eating quality rice using multilines.

Kouji Ishikawa, Tomohisa Kuroda, Takeshi Hori, Daisuke Iwata, Seijiro Matsuzawa, Jun Nakabayashi, Akira Sasaki, Taketo Ashizawa

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Current status of molecular rice breeding for durable and broad-spectrum resistance to major diseases and insect pests.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kouji IshikawaNiigata Agricultural Research Institute, Crop Research Center, Nagaoka, 940-0826, Japan.
Tomohisa KurodaNiigata Agricultural Research Institute, Crop Research Center, Nagaoka, 940-0826, Japan.
Takeshi HoriNiigata Agricultural Research Institute, Crop Research Center, Nagaoka, 940-0826, Japan.
Daisuke IwataNiigata Agricultural Research Institute, Crop Research Center, Nagaoka, 940-0826, Japan.
Seijiro MatsuzawaNiigata Agricultural Research Institute, Crop Research Center, Nagaoka, 940-0826, Japan.
Jun NakabayashiTokyo Medical and Dental University, Bunkyo-ku, 113-8510, Japan.
Akira SasakiThe Graduate University for Advanced Studies, Hayama, 240-0193, Japan.
Taketo AshizawaNational Agriculture and Food Research Organization (NARO), Tsukuba, 305-8666, Japan. toketa@affrc.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combining genetic heterogeneity and crop homogeneity serves a dual purpose: disease control and maintaining harvest quality. Multilines, which consist of a genetically uniform mixture of plants, have the potential to suppress disease while maintaining eating quality, yet practical methods that facilitate commercial use over large geographical areas are lacking. Here, we describe effective rice multiline management based on seed mixture composition changes informed by monitoring virulent blast races in Niigata Prefecture, Japan. The most elite nonglutinous cultivar, Koshihikari, was converted into the multiline, Koshihikari BL (blast resistant lines) and planted on 94,000 ha in 2005. The most destructive rice disease, blast, was 79.4% and 81.8% less severe in leaves and panicles, respectively, during the 2005-2019 period compared to the year 2004. In addition, fungicidal application was reduced by two-thirds after the introduction of BL. Our results suggest that seed mixture diversification and rotation of resistant BL provides long-term disease control by avoiding virulent race evolution.

Indexed as

MagnaportheOryzaJapanPlant DiseasesPlant Leaves

Identifiers

PMID36050381
PMCPMC9436990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.